DISCOVERY
Uncover breakthrough
innovations during the drug
discovery phase.
innovations during the drug
discovery phase.
Josh brings over a decade of experience in Life Sciences, spanning academic research, pharmaceutical innovation, and commercial strategy.
He has led high-performing sales teams and driven growth across clinical trials, medical devices, and post-trial access programs - partnering with both top-five pharma and emerging biotech companies.
Before moving into industry leadership, Josh managed the Neurology Research Institute at The Ohio State University, where he also earned both his Bachelor’s and Master’s degrees in Translational Pharmacology.
He later completed a certificate in AI in Healthcare from Stanford Medicine, adding a tech-forward perspective to his strategic approach. Fluent in English, German, and Spanish, Josh brings a truly global outlook to his role.
His appointment marks an important step in strengthening PLG’s presence in North America — connecting client needs with PLG’s global expertise, and fostering growth through collaboration, insight, and innovation.
